Biochemistry

By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read More

Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read More

Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. Several of these change-makers also donate their time and expertise through the Vanderbilt Innovation Ambassadors Program to help colleagues in their departments recognize and pursue the world-altering potential of their own ideas. Read More

Vanderbilt’s cell and developmental biology department is the third-most NIH-funded in the nation. Biochemistry, pharmacology, and molecular physiology and biophysics are in the top 15. Read More

World-renowned leader in biochemistry David Cortez wins the 2024 Hans Neurath Award for the development and application of creative technological approaches to identify and characterize proteins involved in DNA and genome maintenance.  Read More

The labs of Emily Hodges, assistant professor of biochemistry, and Tony Capra, associate professor of epidemiology and biostatistics at the University of California, San Francisco, have devised a method to separate the relative contributions of cis vs. trans regulatory mechanisms to gene regulatory divergence between species. Read More

Jennifer Pietenpol, Executive Vice President for Research and chief scientific and strategy officer for VUMC and professor of biochemistry and otolaryngology, is the 2024 recipient of the Science of Oncology Award, for outstanding contributions to basic or translational research in cancer. She is among a select group of global oncology leaders being recognized with special awards by ASCO and Conquer Cancer, the organization’s foundation. Read More

Fourteen biomedical sciences students from across the School of Medicine Basic Sciences and the School of Medicine have been awarded the Provost Pathbreaking Discovery Award from the Graduate School. Read More

Congratulations to our School of Medicine Basic Sciences community members who were promoted or received new appointments from January to March 2024! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read More